THE MINIPIG AS A MODEL FOR JUVENILE TOXICITY STUDIES
LEARN HOW TO SELECT THE RIGHT MODEL FOR YOUR JUVENILE TOXICOLOGY STUDIES
The selection of a model for juvenile toxicology studies is essential to ensure that the results will provide an appropriate understanding of safety before progressing into human juveniles. The minipig is an excellent model, as the development pathway is well known, juveniles are a good size to handle, and many of the tissues and organ systems are similar in form and function to humans.
Join us as Sinclair Research presents “The Minipig as a Model for Juvenile Toxicity Studies.” Presented at the virtual ACT 2020 Annual Meeting by Sinclair Research’s Director of Toxicology & Dermatology, Dr. Jeff Klein, this on-demand webinar explores how to select the right model for your juvenile toxicology studies.
In our webinar, Dr. Klein will help you learn:
- The role of minipigs in juvenile toxicology studies
- Insights into current knowledge about study designs and endpoints
- Guidance on how to choose an appropriate animal model for juvenile studies
ABOUT THE PRESENTER:
Dr. Jeffrey A. Klein, PhD, DABT, is a diplomate of the American Board of Toxicology and past president of the Society of Toxicology’s Dermal Toxicology Specialty Section. Dr. Klein is responsible for Sinclair Research’s scientific direction in toxicology and dermatology services and operational processes, bringing decades of experience as both a study director and program manager at CROs and as a Sponsor leading dermal toxicology programs for both pharmaceutical and biotech companies. In addition to his expertise in dermal toxicology, he has a strong background in molecular biology, neuroscience and genetics.